| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da58aee7142b3661f46fdeb213b80fc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2219-00768
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2219-00063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2219-00094 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J19-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J39-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B33-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J19-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J19-0013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 |
| filingDate |
2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06873ff3d8b8249c770b34be63768beb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8b5d07bfb912ef08d57d254dbca4cee |
| publicationDate |
2014-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014113002-A1 |
| titleOfInvention |
Microporous zirconium silicate for the treatment of hyperkalemia |
| abstract |
The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of ZS-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017066128-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10300087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-035890-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11738044-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015374748-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2981272-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015290242-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016038538-A1 |
| priorityDate |
2012-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |